[eu robiologica l fact ors a re important det erminant s of psychi at ric illness. Howeve r , how th ese neu robiological fa ctors lead to t he ob served psychi at ric symp toms is far from clear. Invest iga t ions us in g indirect (e.g . plasma , urine a nd cerebrospinal fluid neuroch e mi st ry, re ceptor expre ssion in periph era l sites ) a nd direct indi ces (e.g. CT sca ns , MRI sca ns, su rface elec t ro phys iolog ica l recordin gs, neuroendocri ne cha lle nges) have confir me d th e ass ociation between neurobi ological fac tors and psychi atric illn esses . H oweve r, in t he ab sence of a com pre he ns ive fram ework for unde rst a nding behavior a nd e mo t ion in th e co n te x t of br ain fun ct ion , th ese findings re ma in iso la ted e m pirica l facts. T he challe nge now is to unit e th ese facts in to a us eful t heore tica l fra m ework-on e which will permi t a pat hop hysiologi ca l und e rst a ndi ng of psychia tric illness, a nd a rat ional ba sis for th e treatment of th ese di sord ers. He rein lies t he prom ise of PET.
PET offe rs th e opport u ni ty to devel op a unifi ed th eory rela t ing e mo t ions and beh avior to neurophysio logica l a nd neuroch emical eve nts in a neu ro a na to m ical Shitij Kapur, M.D. is a res earch fe llow a t th e PET Ce nte r of The C la rke Inst itut e of Psychia try in Toront o, O ntario, whe re Svlvain H ou le. M.D ., Ph .D ., is th e Director a nd an assistant profe sso r of psychi atry and radiology a nd whe re G regory M. Br own , M .D ., Ph.D., is th e Direct or of Research a nd a pr ofesso r of psychi atry a nd ph ysiology. 58 con te xt. T o illustrat e, it is kn own t hat ce r ta in foca l lesion s (e.g . left front al strokes) , or ce r t a in syste m ic neuroch emical alt eration s (e.g. sym pa t ho m im et ic withdrawal ), or pr ofound psych osocial st ress (e .g. d ea th of a spouse) may a ll lead to a dep ressive synd ro me . Furthermore, a ll th e a bove cas es may respond to treatment wit h a se ro ton in-specific reuptake inhibitor (SSRI) a n t ide pressan t. PET offers, at least in principl e, th e oppo r t un ity to uni fy th ese isolat ed fac ts. By e lucidat ing th e network of br ain region s subse rving mood ( I), it m ay help us to u nd e rsta nd why left front al st ro ke s are particularly cr uc ia l in inducin g depressive sym p to ms. By sp ecifyin g how cog nitio n and stress influ ence this network of regio ns, one may u nde rsta nd how sit uat io na l fact ors may induce d epression. By unraveling th e ro le of neurotran smitters in th e m odulation of this ' mood network ' , o ne ma y underst a nd how sym pa t ho mim etic withdrawal indu ces depression and SSRIs treat it (2) .
In this articl e, we review PET as it is rel evant to th e field of psych iatry. The first sectio n will provid e th e read ers with a glim pse into th e ph ysical principl es a nd the instrumentation as rel evant for th e int erpretation of PET st ud ies . T he second section will describe th e ph ysio logi ca l param et ers th at ca n be m easured usin g PET. T he third section reviews how PET st ud ies have con t ribu te d to ou r u nd ers tanding of variou s psychi atric illn esses. Fin all y, we ou t line th e rel ation shi p of PET to other imaging modaliti es and th e future technical a nd expe rime n tal improvem ents which may be import ant fr om th e persp ective of psychi at ry.
HOW IS PET SCANNING DONE?
PET scan ning depends up on th e visualiza t io n of ra dio la bell ed tracers introduced int o th e bod y. The re are two m aj or co m po ne n ts to a PET pro gra m-radioche m ist ry a nd imaging. The acc ou nt below is int entionally brief-for a mo re t horou g h account th e reade r is refe rred to more com pre he nsive so u rces (3) (4) (5) .
R adiochemistry
Th e tracers use d fo r PET a re spe cia lly syn t hes ized mo lecu les whi ch contain a positron-emitting isot op e. Positron-emit ting isot op es of common clem ents like ca rbon , oxyge n, nit rogen a nd fluoride (C, 0 , Nand F resp ecti vely) are pr eferred since t hes e ele me nts naturall y occ ur in a wide variety of biologica lly relevant mol ecul es. These isot op es have sho r t h al f-li~es (IIC -20 m inu tes , 15 0 -2 m inu t es , 18F_110 minut es ) whi ch necessitates a cyclo t ro n fac ility, whi ch ge ne rates th e isot op es, eit her on-sit e or near th e scanning facility. Once the isotope is prod uced , it is inco r po ra ted int o t he mo lec ule of int erest (e .g .
15 0 is incorpo ra ted in water for blood flow st ud ies, a nd may a lso be inhal ed in a gaseous form ; 18F is a ttached to deoxyglucos e for glu cos e m et ab ol ism s t udies; IIC is incorporat ed in to raclop rid e, res ult ing in "C-r aclopride, wh ich binds to dopam in e D 2 recept ors). This pro cess of incorporating th e isot op e into t he t racer age n t is pa rticul arly dem an din g since high levels of che m ica l purity a nd spec ific-ac t ivity hav e to be ass ure d in a sho r t period of ti m e as th e isot opes arc rapid ly decaying .
Imagin g J EFFERSO N J O URNAL OF PSYCI IIATRY
Th e sca n ning is done with th e su bjec t lyin g hori zont all y. T he t race r is administe red via an inj ecti o n or, if gase ous, via inhal ation. Th e a mo u nt of rad ioact ivity a d m iniste re d, the tim e o f ad m inis t ratio n, a nd th e durat io n of uptak e all vary d epending upon the exac t nature of th e trace r a nd the p u r pose of th e study. As th e tra cer undergoes rapid d eca y it e m its positrons . The po sitron , a posi t ive ly cha rge d particle , travels a sho r t di st ance (less than 3 m m ) in th e t issu e a nd th en com bines with a n elect ro n. This co m bina tio n leads to th e ge nerat io n of two 5 11 keY ph ot on s which trav el in diam etrica lly opposit e directi on s. Th e ring of hi gh -se nsi t ivity de tectors su rro u nd ing th e head (t he ca mera) d et ect s th ese ph o to ns. As t he two ph ot on s e m itted fro m a single positron-el ectron co m binat ion, travel ing in diam etricall y opposit e directions, st r ike tw o di ametrically op pos ite d et ect ors, a 'coinc ide nce eve n t' is record ed. The co inc ide nce eve n t is th e building block of t he PET im a ge . Thousands o f suc h co inc ide nce eve n ts a re record ed during each scan and are used to reconstruct the imag e of th e tracer di stribution in th e head . This reco ns truc te d im ag e co nst it u tes the PET sca n . With kn owl ed ge o f the a mou nt of tracer inj ect ed , and its di stribu tion within the different bod y co m par t me n ts, th e ac q uire d image can be co nve rted in to quantit ative physio logica l data . For exa m ple, a PET im a ge obtained wi th Iluorod eox yglucose as a tra cer ca n be co nve rted int o a me tabolic image whi ch es t ima tes regi on al brain m etaboli sm in t erm s of milligram s o f g lucose me t aboliz ed per 100 g m o f tissu e per minut e in different part s o f th e br ain . Th us, P ET 1I0t o nly images th e functioning of the b rain , it a lso m ea sures it (6) .
WHAT CAN BE MEASURED WITH PET? S t ud ies d on e with PET in the la st d ecad e ca n be b ro adl y d ivid ed into thre e typ es: cerebral blood flow s t ud ies ; g lucose me tabo lism st udies and neurochemical st ud ies.
Cerebral B lood Flow (rCB F) Studies
Th e tra cer used for rCBF im a gin g is usu all y wa te r co n tam mg 150, inj ect ed intraven ou sly. Th e sca n ning begins im m edi a tel y aft er the inj ection and last s 60-120 seconds. 150 ha s a sho r t hal f-li fe a nd th e t r acer decays a lmos t co m ple te ly within 10 minut es of inj ection. Thi s a llows th e procedu r e to be re peated u p to 12 tim es in a si ngle session (7) . rCBF close ly refl ects region al neurona l activity (8) , a nd hen ce , by repeating scans whil e the subject is e nga ge d in diffe re nt tas ks, and by co m pa r ing th e brain regions ac tiva te d in th e different ta sk s, o ne ca n di scern t he br ai n regions involved in speci fic cogni tive ope ra t ions (9) (10) (11) . In a p rot o typical application of thi s st ra tegy, Pe t e rsen a nd co lleagues (10) scanned subjec ts d u r ing three different cognit ive t ask s-pa ssive viewi ng of present ed word s, o ra l repet it ion of pr es ent ed words, a nd ge ne ra t ion o f verbs associat ed wi t h the present ed wo rds. By co m pa r ing t he rCBF scans ob taine d during t he d iffere nt ta sk s t hey were able to d elin eat e a reas of the brain whi ch were involved in th e visu al recognition of wo rds, in th e production of sp eech, and in th e act of semantic association (10) .
Cerebral Glu cose M etabolism (rCM Glu) S tudies
The tracer, 18F-fluo ro-deoxyglucose (FDG), is tak e n up by th e tissu es in a mann er sim ila r to naturall y occ ur ring gluco se, but o nce insid e th e ce ll, FDG does not undergo furth er m et abolism and is trapped (12 ) . The tracer is inj ect ed int ravenously, a nd is tak en up by th e brain over th e next 45-60 minut es. Tracer ' uptake' is proportion al to th e rat e of glucose met ab oli sm in a give n region and reaches eq uilibrium in 45-60 minut es. Once eq uilibrium is reach ed the scanning begin s a nd may require 15 to 30 minut es to acq uire a high-resolu ti on image (12) . An import ant di fference bet ween a rCBF a nd a rCMGlu PET sca n is th a t t he form er refl ects br ain activit y ove r 60-90 seconds wh ereas th e latt e r reflect s ac tivity over 45-60 minut es. In add it ion, 18F has a much longer half-life, and th erefore th e FD G scans ca nnot be repeated within a single session. Since 150-wat er scan s reflect bra in activity over bri efer epoc hs and ca n be rep eat ed multipl e tim es wit hin a sess ion , t hes e sca ns a re th e pr eferred m easure for com pa ring neural acti vity in di ffe ren t cog ni tive, e mo tiona l o r se ns ori-mo tor tasks ( 13) .
N eurochemical S tudies
Thes e studies use specific ligands to det ermine th e conce n t ra tio n a nd distribution of receptors, neurotran smitters, a nd o t he r neuroch e m ical s within th e br ain ( 14, 15) . For exa m ple, raclopride, a n a n tipsyc ho t ic which bin ds to th e dopamin e D 2 receptor is fr equently used. IIC lab eled racloprid e ca n be used to visu a lize t he level of D 2 dopamin e recept or s in th e hum an st ria t u m, a nd to com pa re th e leve l of th ese receptors in th e st ria t u m of pati ents with schizo p hre nia to th ose of normal con t rols (16) (17) (18) . Thes e studies involv e the synthesis of a positron-emitt er eIC o r 18F or 76Br), incorporation of th e isotope into th e tracer mol ecul e, inj ecti on of th e tra cer, PET sca nning, a nd finall y, application of mathematical mod els to convert th e image into qu antitative es timates of th e conce n t ra tion of th e receptor o r neuroch e mi ca l (19, 20) . As newer ligands are being syn t hes ize d more a nd m or e rece pt or s an d neuro t ra nsm itters a re becoming accessible to in-vivo m easurem ent (2 1).
SAFETY
The radiation exposure fr om a PET scan is co m pa ra ble th at of ot he r diagnostic procedures used in nuclear m edi cin e, a nd th erefore is easily d efensible in patients wh o a re receiving direct ben efit from th e investigation. Th e issu e is more complex wh en th es e t echniqu es are used in normal volunt eers or in research st udies whe re th ere is no direct ben efit to th e patient. The radiation ex pos ure fro m a PET scan is d et ermined by th e nature of th e tracer, th e amount of radi oactive m at e rial adm inistered, rout e of administration, a nd th e total number of scans. As a br oad ge neraliza-tion, th e ex pos u re m ay vary fro m a fifth to nearly doubl e of wh at th e norm al population receives from background radi ation so urces wit hin a yea r. In keeping with this, m ost research ce n te rs limit th e number of t imes a normal volunt eer ca n particip at e in PET ex pe rimen ts a nd th e number of scans a volunt eer ca n undergo in a sing le st udy.
PET STUDIES OF RELEVANCE TO C LINICAL PSYCHIATR Y

Schizophrenia
Th e m ost e nd uring PET finding in schizo phrenia is th a t of frontal dysfuncti onthe pioneering st udies by Bu ch sbau m e t al. report ed " fro nt a l hypo me ta bolism " (22) (23) (24) (25) ; a findin g whi ch ha s since been ob served by m ost (26-28) , though not a ll g ro u ps (29, 30) . C leg ho rn e t a l. (31 ), on th e ot he r hand , report a relative front al hyper-m et ab olism . PET sca ns of pati ents have been compared to con t rols whil e both were und ert aking a sm oot h-purs uit eye-t racking task (32, 33) , and whi le performing tasks requiring sus taine d a t te n tio n (25,3 4,35); both representi ng tasks on which patients with schizophrenia typi call y show impaired perform a nce. T ask-based comparison s accen t ua te th e resting-st at e differen ces bet ween nor m a ls a nd patients in th e front al lob es (25, (32) (33) (34) (35) sugges ting t hat no t only is t here a frontal dysfunction a t rest , but th at th e resp on se of th e frontal lob e to t he task d emands is also d eficient in patients with schizo p hre n ia (36) (37) (38) . In addit ion t o invest iga tio ns of th e frontal lobe , th e role of th e t emporal lob e (24,39-41 ) , pari et al lob e (40 ,42) , and hemisph eri c asy m me try ha ve been eva luate d usin g PET (43,44) t hough th e PET evide nce for impairm ent in th ese reg ions is less co nverge n t (45) .
St udies have soug h t to cor re late clinical sym p to ms to regional brain abnorm aliti es (27, 46 ). It appears th at t he onse t of sym pto ms may be associat ed with front al hyp er-functi on (31) , whil e wit h ch ro nicity of sym p toms and neuroleptic treatm ent th e picture m ay cha nge to one of front al hyp om et ab oli sm (27,3 1,32) . C leghorn a nd colleagues (47) com pared patients who were ac t ively hall ucin a t ing to those who we re not a nd found th at pat ients with ac t ive hallu cin ati on s had sig nifica nt ly lowe r m et aboli sm in th e a uditory a nd W ernick e's a rea a nd a high e r me tabo lism in Br oca's a rea. Liddl e a nd colleagues (48,49) report a correlation be tween psychomotor poverty and left dorso-Iat eral pr efrontal co r tex a bnormaliti es, con ceptual disorganization a nd a nterior cing ula te region abno r malities, a nd hallucina tio ns and delu sion s a nd m edi al temporal cor te x a bnorm a lity. Relating ph en om e nology to abnormalities in d iscr et e bra in syste ms raises th e possibility of a brai n-based un derstanding of th e different syndrom es a nd su b-synd romes of this com plex illn ess.
Th e dop amine hypothesis of sch izophrenia is one of t he most en during neuroche m ica l hypotheses of sch izophre nia. H owever, dop am in e receptor studies using PET have yie lde d co nflict ing findings (50) . W on g an d colleagues (5 1-53) report ed a 2.5-fold in cr ease in th e dopamine D 2 recept ors in th e ca uda te-putamen of pati ents with schizophreni a using IIC-N-m ethylspiperone as a ligand. I n co nt rast , Farde (54,55) a nd H eital a (I 8) usin g IIC-ra clo pride as a ligan d , a nd M artino t (56) usin g 76Br-bro molisuride , fail ed to find this incr ease. Differen ces in pa t ie n t selection, differen ces in ligand charac te rist ics, a nd differen ces in th e ma t hematical modeling of th e data hav e been su ggest ed as possibl e ca uses for th e observed differences in results (57) . Studies with newer ligands will be required befo re t he issue of D 2 dopamine recept ors in sch izophreni a is concl us ive ly resolved (52, 55, 58) .
There is gre a te r conve rge nce, on th e o t he r hand , among stud ies investigating th e rel ationship between D 2 recept or bindin g a nd neu role pt ic treatment. The percent occ upa ncy of th e dopami ne receptors in th e st ria tum is closely related to plasm a neurol eptic levels, though cha nges in receptor occ upancy lag behind th e changes in plasm a levels (59-61). At th e usual clinica l dose, typ ica l neurol ept ics occ u py 70%-85% of th e availa ble D 2 receptors, a n effec t t ha t is ac hieved, in most cases, a t doses eq uiva le nt to a bo ut 150 mg of chlor pro mazine (62) (63) (64) (65) (66) . T he atypica l neuroleptic clozapine, on th e other hand , shows a lower occ upancy of D 2 receptors (30-50%) and a higher occupancy of D) and pos sibl y S2 recept or s (62-67). Receptor occupancy, beyond a cert ain threshold, d oes not see m to incr ease th erapeu tic effects but do es tend to incr eas e th e level of ex t ra pyra m idal side-e ffec ts (68-7 1). Ta ken together th e evid ence suggests th at with typic al n eurol eptics, a ce r tai n level of D 2 receptor occupancy (70% or great er) is necessary, but may not be sufficient for a th erapeutic effec t. In addition to blocking th e recept ors, neu rol e ptics increase m et ab olism in th e ca uda te-put a me n (30, 40, (72) (73) (74) (75) . At pr ese nt th e rel eva nce of th is findin g is not clear. However, as th e rol e of th e st ria t u m in cog n it ion is unraveled furth er, it may becom e possibl e to underst and th e mechanism of neuroleptic m edi cations in t erms of th eir neu rom odul at ory effec t o n t he stria tum (75) .
These initial st ud ies in schizo phre n ia have offere d promising leads. First, th ere is st ro ng evide nce for fr ont al dysfuncti on in sc hizophre nia , both at rest and whil e e ngaged in specific tasks; ot he r co r t ica l a nd subco rt ica l regio ns may also be invo lved . Seco nd, g ro ups of sym pto ms ca n be relat ed to a dysfuncti on of spec ific brain regions. Th ird , neu rol eptic d ru gs produ ce sig nifica n t changes in bra in me tabolism in th e st ria t u m via th e occu pa ncy of dop am ine recepto rs. Fourth, a high level of dopam ine D 2 recept or occupancy is necessa ry for clinica l resp on se, bu t is not sufficient by itself. Fifth, th e differen ces in th e clinica l profile of typi cal ve rs us a typica l neu rol e ptics may be rel at ed to th e differen ces in th e occ upa ncy of th e D 2 a nd D ) a nd possibly S2 receptors. Thes e findin gs are preliminary, but th ey offer th e hop e of d eveloping a co m pre he nsive underst anding of th e pathophysiology of sc hizo phre n ia an d a rat ional a ppr oach to its treatment.
AJfective Disorders
PET has mad e possibl e th e study of th e neuroan at omical pa th ways mod ula t ing mood. Pardo and colleag ues have report ed th e involvem ent of t he infe rior fronta l co r te x in se lf-ind uce d dysphori a in normal subjects (I ). In pa t ie n ts, depress ive sym pto ms a re associa te d with a hypo-p erfusion a nd hypo-m et ab oli sm in t he prefrontal cor te x (6, (76) (77) (78) (79) (80) . It is unclear if this defect is sim ila r to th at see n in schizophrenia (8 1); it has rece ntly been suggested th at pr efront al hyp o-met a bolism may reAect psych om ot or poverty, a nd th a t this m ay be t he reason for prefront al hypom et ab olism bein g observed in both schizo phre nia a nd d epression (82) . Pr efront al cor te x hypo-m et ab olism see ms to be correlated wit h symptom seve rity a nd a resolution of clinica l sym pto ms is acco mpanied with a t re nd towards normalization of thi s defect (78,83 ,84) . In addition to th e fron tal hypo-m eta bolism , s tud ies have re ported a n involve m en t of t he ca uda te -p u tamen (85) as we ll as lim bic structures in d epr ession (6, 80) .
Previou s st ud ies investi gating th e neu ro ch e m ical cha nges accom pa nying depr ession had to infer changes in th e brain via pe ripheral measures suc h as receptors on peripheral ce lls or t he neu ro transm itter metabo lites measured in th e ce re bros pina l fluid , plasm a a nd u rin e . PET m ak es possibl e direct, in-vivo m easures. Kishimot o a nd co lleagues (86) , usin g radi olab ell ed a m ino ac ids, report ed a signifi cant decr ease in th e a mi no ac id pool in pat ient s wit h d epression a nd a significant increas e in patients wit h m ania. Agr en a nd colleagues (8 7) re po rted a d ecr eased transportation of "C-L-5-hydroxytryp to p ha n ac ross t he blood -brain barrier in pa tien ts with depression. Us ing lIC-N-me t hylspipero ne (lIC -N MS P); a ligand which binds to th e dop amine D 2 a nd se roto n in S2 rece ptors (88) , M ayberg a nd colleagues (89) rep ort t hat after unil at eral st ro kes, IIC-N MSP binding negat ively cor re la te d with th e d egr ee of depressive sym p to ms. This suggests t hat a decr ease in se ro tonin S2 receptor nu mb er or a n in abili ty to up-regul a te S2 rece ptors in t he ipsilat e ral hemisphere a fter a stroke may be associa te d wit h t he symptoms of depression .
T hu s, metabo lic PET st ud ies in dep ression implicat e th e pr efront al cortex, th e cauda te -pu ta men, a nd lim bic structures as candidat e st r uc t u res subse rving mood ( 1,6,80). T hese find ings help explain, a t least in part, th e incr eased pr op en sit y for developing depression secondary to stroke involving th e front al cortex, Parkinson 's disease a nd H untington 's disease. T he neurochem ical a nd neuroreceptor stu dies using PET in de pression have demonstrated the potential of in-vivo study, bu t t her e are few convergen t or re plicated find ings. What is ne ed ed now a re syste matic stu d ies which on th e one hand identify t he ne u ronal and neuroch emical cor relates of de pressive sym pto ms, a nd on the other hand de lineate th e neuroch emical effects of a nt ide pressan ts which a re cr ucial for th e resolut ion of mood symptoms.
Obsessive Compu lsiveDisorder (OCD)
In a se ries of pion eering st ud ies Baxt er a nd colleagues descri bed an elevation of . m et abolism in the right orbital gyr us a nd th e ca udate nu cleu s in OCD (90,9 1). Subse q ue nt st ud ies by Baxt er a nd colleague s a nd by other groups with more ca refully se lec te d dru g-free non-depressed O CD patients confirmed this finding (90) (91) (92) (93) . C linica l improvement, wh ethe r du e to ph a r macological treat me n t (fluox etine and clo m ipram ine) or beh avior th erapy is associa ted wit h a normalization of th e st ria ta l hyper-m et ab olism (93) (94) (95) .
These find ings suggest th a t sym ptoms in O CD resu lt from the gen eration of se lf-s us taining, improp erl y inhibited , positive feed back loops of motor and cog ni tive ac tivity in fr ontal-striat a l/limbic-th al a mi c circui ts (96) . In a symptom induction st udy, Rauch a nd co lleagues (97) scanned pa ti en ts with O CD whi le in an asymptoma tic sta te a nd subse q ue n t ly whil e expe rie nci ng expe rim e nt a lly-ind uce d obsessiveco m pulsive sym p to ms. Th e sym p to ms were associated wit h an increased rCBF in t he front al-striat al-limbic circ uit providing suppo rt for th e a bove described mod el (9 7) . It is remarkabl e that with th e advent of fun ctional im agin g, in-vivo evide nce is now ava ila ble to identify a neurobiological ba sis for a n illn ess wh ich un til recently was cons ide re d a protot ypi cal 'func t ional neurosis'. This does not sugges t t ha t psychodynamic principl es a re supe rfluo us, but it does sugges t th a t th e d ich ot om y between fun ctional a nd orga nic illn esses m ay no lon ger be t en abl e. In fa ct, psych odynamic a nd biological expla na tions m ay be two co m plime nt a ry levels of a bs tractio n with which to und erstand th e symptoms of OCD. Each fram ework m ay offer un iqu e insights and uniqu e treatm ents.
A nxiery Disorders
Anxiet y dis orders a re th e mos t co m mo n of psych iat ric d iso rd e rs, a nd ye t little is known abo u t the neuroanat omical basis of a nxiety (98) . Ini t ial PET st udies of patients with panic dis order sugge ste d that a t least a subse t of them showed m etabolic asymm etry in th e hippocampal region (99) . T o tes t th is hypot hesis, Reim an and colleague s (100-102) induced pani c a ttacks in susceptible subjects during th e PET scan it self a nd found sign ifica n t increases in the rC BF in th e t emporal poles, in sul ar cor te x, cla us t ru m a nd put a m e n. H oweve r , th es e findi ngs hav e subse q ue ntly been qu estion ed a nd o t he r groups fa il to find t he sa me result s ( 103).
Dementias
Althou gh no pathognomonic patt ern of br ain dysfunct ion d ia gn osti c of dem entia has e me rge d , patients with Alzh eimer's di sease do show a re la tive reducti on in me tabo lism in th e front al a nd te m poro-pa rie tal associa t ion areas wh en com pa re d to age-ma tc he d con t ro ls. Th ere also se e ms to be an inve rse corre lation between ove ra ll sym p to ms a nd region al m et ab olism ( 104) . In add it io n, t he re seems to be a significa nt loss in th e serotonergic receptors in front al a nd t emporo-pa ri e t al co r t ica l regions (105) . The effec ts of th e d em en ting illn ess a re hard to di st ingu ish since th ey a re confo u nde d by th e effec ts of norm al ag ing o n m etabo lism ( 106, I07) , receptors (88) , a nd st ruct u ra l a trophy. While a t t his ti m e th e clin ical ut ility is limit ed , it is hop ed th a t with th e a pplica t ion of advance d statis t ica l method s (108) and cog ni t ivecha lle nge t echniqu es (109 ) PET could play a n import an t rol e in th e ea rly dia g nosis of dem enti a ( 108, II 0) , in differentiating Alzh eim e r 's d isease from m ulti-infarct dement ia ( 111-113), a nd in distingu ish ing d e m e nt ia from depression ( 114) a nd ot her confou nd ing illnesses ( I I I) .
PET AND OTHER IMAGING MODALITIES J EFFERSON JO URN AL OF PSYC HIATRY
PET provides th e information a bo u t brain fun ction. CT a nd th e MRl t echn iqu es , on th e other hand , provide t he neuroanatomical inform ation. The techniq ues complem ent each other, and by co-registe ring a MRI scan of a given indi vidu al to t he ir PET scan th e ana tomi ca l precision of t he in terp re ta t io ns of th e PET d at a may be improv ed ( 115) . Recen tly, M RI scanners have been us ed to obtain infor ma t ion about regional cha nge s in hemoglobin sa t u ra t ion ; a t echniqu e whi ch provid es in for m a t io n similar to that obt ained from PET rCBF st ud ies (116) (117) (118) . This t echniq ue of " fu nc t iona l M RI" is new, but o nce sta nda rd ized , offers th e pot ent ial of providing inform ation reg arding rCBF with g rea te r a na to m ica l pr ecision a nd no radiation risk . Nuclear magn etic resonance sp ectroscop y us es m a gn etic reson an ce for measuring th e level of neuroch emical m et ab olit es in different region s of t he bra in (119) . Th e m etabolit es m easured are different from those assessed usin g PET and t he refore th e two techniq ue s ca n co m ple me n t eac h other.
Single photon e m issio n com pu te d tomography o r SPECT is a n im a gin g modality which is fun ctionally sim ila r to PET . Th e maj or differen ce between th e two is th e na ture of t he tracer and t he d egree of spatial resolution . T race rs used in PET imagin g invo lve sho r t-lived isotopes of C , N, 0 a nd F. Whil e thi s pe rmits th e producti on of a wid e vari et y of biological age n ts, it necessit at es a cyclo tron for th e producti on of th e tracers. SPECT im a gin g, o n th e ot her hand , incorpo ra t es long-lived isotopes of technetium and iodine. Si nce th ese ele me n ts do not natu rall y occur in a wid e va rie ty of biologica l che m ica ls, it limits th e va rie ty of co m po unds whi ch ca n be produced , but since th e half-life of th e tracers is lon g, th e tracers ca n be pr od uced a t a remot e sit e and shipped to t he ca me ra -site for im a ging. Th e pr esent ge nera tion of PET ca me ras provid e a hig he r d egree of spa t ia l resolution ; however, wit h increasing sophisticat ion in SPECT t echnology this differen ce in resolution is na rrowing. Thus, PET im aging, du e to th e wider ran ge of ava ila ble liga nds a nd high e r resolution, may be more usefu l as a research tool in th e initial stages of investi gation . SPECT, du e to it s lower cos t and gre a te r ava ila bility, would be th e ve hicle for t he wider diss eminati on of th e us eful research a nd clinical a pplica t io ns d e rived from initi al PET studies .
PET AND PSYCHIATRY-WHAT DO ES THE FUTURE HOLD?
The PET t echnology is undergoing co nt in uous imp rov em ent ; th e in-p lan e reso lution has reach ed th e th eo re t ica l max im um of about 3 mm . (3, 5) . PET an d M RI im a ges ca n be co-regist ered using a u to ma te d software (120-1 22) . Aut om at ed met hod s a re now becoming avai lable for image a na lysis (123) (124) (125) . In addi tion , new statistical m ethods are being d eve lop ed which will permit th e co m parison of brain networks rathe r than sing le region s (126) (127) (128) (129) (130) .
It is now well recognized th at dyn amic test s, suc h as t he ca rd iac stress t est a nd th e gluco se tol erance test , a re more se ns it ive a nd spec ific meas ures of t he fun cti onal status of th e respective ph ysiological sys te ms th an base line m easures. Su ch a p-proaches sho uld now be im ple m e n t ed in th e fie ld of psychi a try using PET. Fo r exa m ple, rather th an co m pa ring schizoph re nic pa ti ents with con t ro ls at rest , pati ents shou ld be st ud ied while e ngaged in cognitive tasks whi ch best d iffe renti a t e th em be haviorally from th e ir co nt ro ls. Thereby , on e would not only ident ify br a in abnormaliti es, but more us efu lly, und erstand brain abnorm aliti es which a re specifica lly rel a t ed to th e fun ct ional d eficits shown by th e patients (36, 38) . Mood stat es a nd anxie ty levels ca n be modified expe rime nta lly in safe and e t hica l paradi gm s. Standardized "emotio nal challe nges " shou ld be d eveloped and used with PET to delin ea t e t he ne ural netwo rk s which subserve m ood ( 1,2,9 7, 102, 103 ). Moreov er, PET permi ts t he in vivo st udy of t he in teracti on of p harmaco logi ca l, cog nit ive, a nd e mo t iona l stat es (13 1,132) . These approach es could be com bine d and th e behavior al effec ts of drugs could be und erstood in term s of their neuroan atom icall y spec ific mod ulat ion of networks. Su ch st ud ies may pe rmit us to develop a com pre he ns ive neurobiologica l framewor k of hu m a n e mo t ion an d behavior as a basis for und erstanding psychia t ric illn ess (2) .
Th e find ings whi ch will e merge usi ng these new techniqu es and paradigm s, in a ll likel ih ood , will not accommodate th emse lves in ou r pr es ent co nce pt ua l niches. D ia gnostic syst ems, ou r abi lit y to classify and ca te go rize obs ervabl e ph enom en on , a re th e bedrock of scientific research and se rve th e purpose of identifyin g a rela tively homogenous group of patients who ca n th en be st ud ied and with resp ect to whom pr ed ict ions ca n be made. As op posed to th e rest of mod ern m edi cin e wh ere nosology is pri marily pathop hysiology-b ased, t he presen t syst em of classification in psychi a try is bas ed on t he ident ification of a clust er of symptoms. W h ile su ch di agnostic systems have and may cont inu e to serve us we ll clini ca lly, this may not be th e best way to id e nti fy homogenous groups of patients for neurobiological research . Th e real challe nge th en, will be to go beyond our cur re nt diagnostic co nst rai n ts a nd look a t th e symptoms that cu t across syndromes and syndrom es th at cu t ac ross disorders (82) . For exa m ple, t he sa m e brain syste ms may subserve psychomotor poverty, irresp ective of whe t he r th ey are encoun tered in d epression o r schizophren ia. On t he oth er ha nd , different bra in sys tems may subserve psychomotor poverty and delusions /h allucinations even t ho ugh t hese symptoms are clustered together und er th e di a gn osis of sc h izo phre nia (82) . Thus, brain-based physiological syst ems, in add it ion to ph en o me nologica l clus tering, may be com e t he basis for di agnosing a nd treating psych ia tric illness (2, 36, 133) . PET has opened th e window to th e br ain-th e next decad e will d et erm ine if it will change ou r vision of mental illn ess.
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